Rolfo, CHRISTIAN DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 3.820
EU - Europa 658
AS - Asia 252
SA - Sud America 5
OC - Oceania 2
Totale 4.737
Nazione #
US - Stati Uniti d'America 3.817
IT - Italia 247
CN - Cina 192
FI - Finlandia 72
GB - Regno Unito 65
IE - Irlanda 63
DE - Germania 59
SE - Svezia 35
RU - Federazione Russa 30
RO - Romania 16
BE - Belgio 13
ES - Italia 12
KR - Corea 10
IN - India 9
TR - Turchia 9
FR - Francia 7
UA - Ucraina 7
IR - Iran 6
NL - Olanda 6
CH - Svizzera 5
GR - Grecia 5
HK - Hong Kong 5
JP - Giappone 4
CA - Canada 3
CL - Cile 3
CZ - Repubblica Ceca 3
RS - Serbia 3
SG - Singapore 3
UZ - Uzbekistan 3
AT - Austria 2
BR - Brasile 2
HR - Croazia 2
LB - Libano 2
PL - Polonia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
MC - Monaco 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VN - Vietnam 1
Totale 4.737
Città #
Fairfield 723
Ashburn 359
Woodbridge 355
Seattle 308
Chandler 307
Houston 303
Cambridge 275
Wilmington 258
Ann Arbor 167
Palermo 69
Medford 67
Dublin 62
Altamura 51
Princeton 42
Nanjing 41
Des Moines 39
Lawrence 38
Twinsburg 32
New York 31
San Diego 27
Dearborn 25
Beijing 24
Nanchang 19
Boardman 18
London 18
Ludwigshafen am Rhein 17
Redwood City 16
Shenyang 16
Phoenix 14
Brussels 13
Changsha 13
Hebei 11
Jinan 11
Tianjin 11
Tulsa 11
San Paolo di Civitate 10
Chicago 9
Helsinki 9
Jiaxing 9
Los Angeles 9
Milazzo 9
Rome 9
Izmir 8
Seongnam 8
Ningbo 7
Bremen 6
Madrid 5
Milan 5
Saint Petersburg 5
Zhengzhou 5
Guangzhou 4
Norwalk 4
Orange 4
Parma 4
Amsterdam 3
Detroit 3
Edinburgh 3
Hangzhou 3
Pune 3
Renton 3
Shanghai 3
Tappahannock 3
Tokyo 3
Absecon 2
Athens 2
Bangkok 2
Barcelona 2
Catania 2
Central District 2
Chiswick 2
Dolovo 2
Durham 2
Falls Church 2
Frankfurt am Main 2
Hong Kong 2
Hounslow 2
Islington 2
Kilburn 2
Kumar 2
Kunming 2
Messina 2
Moscow 2
Naples 2
Novokuznetsk 2
Prescot 2
Rootstown 2
Sector 6 2
Taizhou 2
Utrecht 2
Zagreb 2
Zweidlen-Dorf 2
Acton 1
Ada 1
Afragola 1
Ascoli Piceno 1
Bagheria 1
Baotou 1
Belgrade 1
Brampton 1
Bucharest 1
Totale 4.012
Nome #
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 187
Exosomes in semen: Opportunities as a new tool in prostate cancer diagnosis 169
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 165
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 161
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 160
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 157
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 157
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 156
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 148
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 146
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 141
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 136
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 133
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition 133
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward 130
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 129
Cancer and the microbiome: Potential applications as new tumor biomarker 128
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 127
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 126
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… 122
Multisciplinary management of patients with liver metastasis from colorectal cancer 121
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 115
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment 115
Exosomes as diagnostic and predictive biomarkers in lung cancer 114
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy 112
Targeting angiogenesis in biliary tract cancers: An open option 111
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 107
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis? 107
Improving extracellular vesicles visualization: From static to motion 107
Ramucirumab and its use in gastric cancer treatment 102
BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door? 101
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 101
Effects of exosomes released by NSCLC cells on osteoclasts differentiation. 99
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 98
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 91
Role of NSCLC exosomes in osteoclast differentiation 74
VIPoma and PPoma 73
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 67
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia cells 63
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 57
Indications for locoregional tumor therapies: CRC liver metastases 54
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 44
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 39
null 16
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors 8
Liquid biopsy: a right tool in a right context? 6
Totale 5.013
Categoria #
all - tutte 17.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019351 0 0 0 0 0 0 0 0 0 66 135 150
2019/20201.670 140 68 97 374 189 186 150 127 142 98 66 33
2020/2021756 62 27 50 56 65 69 52 66 53 132 69 55
2021/2022574 31 107 30 20 19 27 20 45 61 81 45 88
2022/2023811 73 168 36 112 83 122 29 61 66 3 39 19
2023/2024304 14 48 26 26 19 56 63 23 18 11 0 0
Totale 5.013